{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-26-000067","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2026-07-23T10:46:37+00:00","discovered_at":"2026-07-23T10:50:00.258616+00:00","generated_at":"2026-07-23T10:50:07.081550+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Quest Diagnostics Q2 revenue up 10.2% to $3.04B; raises FY2026 guidance","bullets":["Q2 revenue $3.04B (+10.2% YoY), organic growth 10.0%.","Reported diluted EPS $2.84 (+15% YoY); adjusted diluted EPS $3.12 (+19.1% YoY).","FY2026 revenue guidance raised to $11.95B-$12.05B; adjusted EPS guidance raised to $11.05-$11.25.","Q2 cash from operations $597M, up 9.7% YoY.","Advanced Diagnostics growth (Alzheimer's, cardiometabolic); NY approval for Haystack MRD test."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-26-000067","json":"https://secwatch.observer/filing/0001022079-26-000067.json","markdown":"https://secwatch.observer/filing/0001022079-26-000067.md","text":"https://secwatch.observer/filing/0001022079-26-000067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207926000067/0001022079-26-000067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207926000067/dgx-20260723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T10:50:07.081550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}